New Class Of Highly Selective 5-HT4 Receptor Agonists Provides The Next Generation Of GI Treatments

A scientific review of the different pharmacological profiles of 5-HT4 receptor agonists published in Neurogastroenterology and Motility concludes that, due to a more selective mode of action, next-generation 5-HT4 compounds are expected to be safer and more effective treatment options for common, debilitating gastrointestinal (GI) motility disorders such as chronic constipation (CC) and gastroparesis1.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on February 7th, 2008